Mengnan Li

Mengnan Li

Auto-generated profile, based on publicly available information

Mengnan Li

Laboratory for Cell Polarity and Organogenesis, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 March 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
WXWeidong Xie
Weidong Xie
MLMengnan Li
Mengnan Li
Naihan XuNaihan Xu
Naihan Xu
QLQing Lv
Qing Lv
NHNunu Huang
Nunu Huang
YZYaou Zhang
Yaou Zhang
MiR-181a has been presumed to target the 3′-untranslated regions (3′-UTR) of IL1a based on software predictions. miR-181a and IL1a have opposite expression levels in monocytes and macrophages in the inflammatory state. This led us to suspect that mir-181a has an important function in regulating inflammatory response by targeting IL1a. Fluorescence reporter assays showed that miR-181a effectively binds to the 3′-UTR of IL1a. The anti-inflammatory functions of miR-181a were investigated in lipopolysaccharides (LPS)-induced Raw264.7 and phorbol 12-myristate 13-acetate (PMA)/LPS-induced THP-1 cells. We found that miR-181a mimics significantly lowered IL1a expression levels in these cells and, interestingly, miR-181a inhibitors reversed this decrease. In addition, miR-181a mimics significantly inhibited increase in the levels of inflammatory factors (IL1b, IL6, and TNFa) in these cells. Furthermore, miR-181a mimics and inhibitors decreased and increased, respectively, production of reactive oxygen species in PMA/LPS-induced THP-1 cells. These results indicate that miR-181a regulates inflammatory responses by directly targeting the 3′-UTR of IL1a and down-regulating IL1a levels. Interestingly, we found that miR-181a inhibited production of inflammatory factors even in IL1a-induced THP-1 cells, suggesting that the anti-inflammatory effects of miR-181a possibly involves other targets in addition to IL1a. Thus, we provide the first evidence for anti-inflammatory effects of miR-181a mediated at least in part by down-regulating IL1a.

1 January 2013 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
WXWeidong Xie
Weidong Xie
ZLZhongxin Li
Zhongxin Li
MLMengnan Li
Mengnan Li
Naihan XuNaihan Xu
Naihan Xu
YZYaou Zhang
Yaou Zhang

2 November 2012 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
JHJie He
Jie He
JWJiangbin Wu
Jiangbin Wu
Naihan XuNaihan Xu
Naihan Xu
WXWeidong Xie
Weidong Xie
MLMengnan Li
Mengnan Li
YZYaou Zhang
Yaou Zhang
MiR-210 is up-regulated in multiple cancer types but its function is disputable and further investigation is necessary. Using a bioinformatics approach, we identified the putative target genes of miR-210 in hypoxia-induced CNE cells from genome-wide scale. Two functional gene groups related to cell cycle and RNA processing were recognized as the major targets of miR-210. Here, we investigated the molecular mechanism and biological consequence of miR-210 in cell cycle regulation, particularly mitosis. Hypoxia-induced up-regulation of miR-210 was highly correlated with the down-regulation of a group of mitosis-related genes, including Plk1, Cdc25B, Cyclin F, Bub1B and Fam83D. MiR-210 suppressed the expression of these genes by directly targeting their 3′-UTRs. Over-expression of exogenous miR-210 disturbed mitotic progression and caused aberrant mitosis. Furthermore, miR-210 mimic with pharmacological doses reduced tumor formation in a mouse metastatic tumor model. Taken together, these results implicate that miR-210 disturbs mitosis through targeting multi-genes involved in mitotic progression, which may contribute to its inhibitory role on tumor formation.

17 July 2018 in EMBO Reports
Verified
Journal Article
Closed access
PDF file
THTakao Hikita
Takao Hikita
FMFatemeh Mirzapourshafiyi
Fatemeh Mirzapourshafiyi
PBPedro Barbacena
Pedro Barbacena
MRMeghan Riddell
Meghan Riddell
APAyesha Pasha
Ayesha Pasha
MNMasanori Nakayama
Masanori Nakayama

12 March 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
MLMengnan Li
Mengnan Li
Shinya NishioShinya Nishio
Shinya Nishio
CNChie Naruse
Chie Naruse
MRMeghan Riddell
Meghan Riddell
SSSabrina Sapski
Sabrina Sapski
MNMasanori Nakayama
Masanori Nakayama
Enlarged vestibular aqueduct (EVA) is one of the most commonly identified inner ear malformations in hearing loss patients including Pendred syndrome. While biallelic mutations of the SLC26A4 gene, encoding pendrin, causes non-syndromic hearing loss with EVA or Pendred syndrome, a considerable number of patients appear to carry mono-allelic mutation. This suggests faulty pendrin regulatory machinery results in hearing loss. Here we identify EPHA2 as another causative gene of Pendred syndrome with SLC26A4. EphA2 forms a protein complex with pendrin controlling pendrin localization, which is disrupted in some pathogenic forms of pendrin. Moreover, point mutations leading to amino acid substitution in the EPHA2 gene are identified from patients bearing mono-allelic mutation of SLC26A4. Ephrin-B2 binds to EphA2 triggering internalization with pendrin inducing EphA2 autophosphorylation weakly. The identified EphA2 mutants attenuate ephrin-B2- but not ephrin-A1-induced EphA2 internalization with pendrin. Our results uncover an unexpected role of the Eph/ephrin system in epithelial function.

17 December 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
MRMeghan Riddell
Meghan Riddell
ANAkiko Nakayama
Akiko Nakayama
THTakao Hikita
Takao Hikita
FMFatemeh Mirzapourshafiyi
Fatemeh Mirzapourshafiyi
TKTakuji Kawamura
Takuji Kawamura
MNMasanori Nakayama
Masanori Nakayama
Strict regulation of proliferation is vital for development, whereas unregulated cell proliferation is a fundamental characteristic of cancer. The polarity protein atypical protein kinase C lambda/iota (aPKCλ) is associated with cell proliferation through unknown mechanisms. In endothelial cells, suppression of aPKCλ impairs proliferation despite hyperactivated mitogenic signaling. Here we show that aPKCλ phosphorylates the DNA binding domain of forkhead box O1 (FoxO1) transcription factor, a gatekeeper of endothelial growth. Although mitogenic signaling excludes FoxO1 from the nucleus, consequently increasing c-Myc abundance and proliferation, aPKCλ controls c-Myc expression via FoxO1/miR-34c signaling without affecting its localization. We find this pathway is strongly activated in the malignant vascular sarcoma, angiosarcoma, and aPKC inhibition reduces c-Myc expression and proliferation of angiosarcoma cells. Moreover, FoxO1 phosphorylation at Ser218 and aPKC expression correlates with poor patient prognosis. Our findings may provide a potential therapeutic strategy for treatment of malignant cancers, like angiosarcoma.